Product Description
- BrandAbbott
- Sample TypeUrine
- Pack Size24T
- CAT NoD1200E
Brand Abbott
The NMP22 BladderChek Test is a fast, easy to use and non-invasive test that aids in the diagnosis and monitoring of bladder cancer, in conjunction with standard diagnostic procedures. With results in 30 minutes at the point-of-care, results can be delivered to patients during the same office visit, allowing a rapid and cost-effective aid in the detection of bladder cancer in patients at risk.
Rapid Detection for Bladder Cancer RecurrenceAbbott NMP22 BLADDERCHEK provides healthcare teams with swift, reliable insights for monitoring and aiding in the diagnosis of bladder cancer recurrence. With results delivered in about 30 minutes, practitioners can make timely, informed decisions without the need for electricity or complex instrumentation, facilitating convenient integration into clinical routines.
Convenient and User-Friendly DesignEach disposable cassette is individually packaged and color-coded for easy identification. The manual operation and visual line display make the test straightforward to use, requiring only a fresh urine sample and the included dropper. Its lightweight, portable design allows for flexible use across different care settings.
Improved Patient Management in UrologyThis test enhances decision-making processes in clinics, hospitals, and point-of-care settings. With a qualitative readout for NMP22 protein levels, clinicians can effectively monitor patients at risk of bladder cancer recurrence, optimizing follow-up strategies and reducing the need for invasive procedures.
FAQ's of Abbott NMP22 BLADDERCHEK:
Q: How does the Abbott NMP22 BLADDERCHEK test work?
A: The test functions through a chromatographic immunoassay that detects the NMP22 protein, a tumor marker associated with bladder cancer, in freshly voided urine. A visual line appears on the cassette display to indicate the presence or absence of the protein.
Q: What type of sample is required for the NMP22 BLADDERCHEK test?
A: You need a freshly voided urine sample for each test. The kit includes a dropper for precise application to the test cassette, ensuring convenience and accuracy.
Q: When should this test be used in patient care?
A: NMP22 BLADDERCHEK is intended for use by healthcare professionals as an aid in diagnosing and monitoring recurrence of bladder cancer, particularly during regular follow-up visits or when patients show relevant symptoms.
Q: Where can the NMP22 BLADDERCHEK be performed?
A: Testing can be conducted in clinical laboratories, urology clinics, and other healthcare environments. No specialized instruments or electricity are needed, making it suitable for various medical settings.
Q: What is the process for using the NMP22 BLADDERCHEK test?
A: After collecting a urine sample, use the provided dropper to apply the sample to the test cassette. Wait approximately 30 minutes for a visual line to signal the result. The test should be discarded after use.
Q: What are the benefits of using this test for bladder cancer monitoring?
A: The kit provides rapid and qualitative detection of bladder cancer markers, supporting prompt patient management. It reduces reliance on invasive procedures and is convenient for both clinicians and patients.
Q: How should the test kits be stored and how long do they last?
A: Store the kits at temperatures between 2C and 30C. Avoid freezing them. Each test device has a shelf life of up to 18 months from manufacture.